ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,461.50
-0.14%
Dow Jones
38,954.60
-0.40%
US Dollar vs MXN
18.29875
0.95%
Brent Oil
84.17
-0.02%
Bitcoin
61,756.36
-0.09%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Noticias

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AZN
FechaHoraFuenteTítuloSímboloCompañía
26/06/202402:40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
25/06/202403:05Alliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
25/06/202401:05RNS Regulatory NewsAstraZeneca PLC Update on Imfinzi ADJUVANT BR.31 trialLSE:AZNAstrazeneca Plc
25/06/202401:00RNS Regulatory NewsAstraZeneca PLC Imfinzi improved EFS and OS in bladder cancerLSE:AZNAstrazeneca Plc
20/06/202404:56Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
18/06/202403:33Alliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
18/06/202401:00RNS Regulatory NewsAstraZeneca PLC Update on CAPItello-290 Phase III trialLSE:AZNAstrazeneca Plc
17/06/202403:09Alliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
17/06/202401:23Alliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
17/06/202401:00RNS Regulatory NewsAstraZeneca PLC Imfinzi approved in the US for endometrial cancerLSE:AZNAstrazeneca Plc
12/06/202414:56Alliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
12/06/202409:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
10/06/202402:30Alliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
05/06/202403:27Alliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
05/06/202401:00RNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
04/06/202406:00PR Newswire (US)AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024LSE:AZNAstrazeneca Plc
03/06/202409:05RNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
03/06/202409:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
03/06/202402:59Alliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
03/06/202401:00RNS Regulatory NewsAstraZeneca PLC Tagrisso plus chemo recommended for approval in EULSE:AZNAstrazeneca Plc
29/05/202402:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
28/05/202401:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung cancerLSE:AZNAstrazeneca Plc
27/05/202401:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
21/05/202406:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202402:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202402:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202404:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202401:00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Su Consulta Reciente

AMEX
CEV
Eaton Vance California M...
TG
T15B
Tectonic Metals
NYSE
EVT
Eaton Vance Tax Advantag...
USOTC
KBAGF
Koninklijke Bam Groep NV (PK)
LSE
SO14
Citi Fun 24
AQSE
ETH-S.ST.GB
XBT Provider AB
TG
42Z
Revolution Medicines
EU
FR001400PH24
Credit Agricole SA Casa ...
LSE
XMAF
Xafrica 50 Sw
BOV
E1WL34M
Edwards Lifesciences
EU
H797S
H797S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados